A brief report: Cerebrospinal fluid rhinorrhea after repetitive nasal swab testing for coronavirus disease 2019(COVID-19)
View/
Access
info:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttps://creativecommons.org/licenses/by-nc-nd/4.0/Date
2021Metadata
Show full item recordCitation
Yılmaz, M., Bahadır, Z., Madendere, B., Yüksel, R. T., Gökay, H. ve Yiğitbaşı, A. A. (2021). A brief report: Cerebrospinal fluid rhinorrhea after repetitive nasal swab testing for coronavirus disease 2019(COVID-19). Otolaryngology Case Reports, 20. https://dx.doi.org/10.1016/j.xocr.2021.100313Abstract
For the past year, COVID-19 Pandemic has been the biggest focal point of medicine. Due to its novelty and its highly infectious nature, the impact of Sars-Cov-2 on society has been growing rapidly. The primary route for prevention of this highly infectious virus is detection. The detection methods for Sars-Cov-2 include nasal swab tests, saliva samplings and antibody tests. The main preferred method has been the RT-PCR with Nasal Swab sampling which is performed on the nasopharyngeal region. However, the nasal swab testing may come with its own iatrogenic outcomes due to its invasiveness. In this report, we describe a rare case of iatrogenic unilateral cerebrospinal fluid rhinorrhea which occurred due to repetitive nasal swab testing for COVID-19.
xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q4Source
Otolaryngology Case ReportsVolume
20Collections
- Makale Koleksiyonu [3194]
- PubMed İndeksli Yayınlar Koleksiyonu [3494]
- Scopus İndeksli Yayınlar Koleksiyonu [5333]
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
